Eyes are on a water retention drug called bumetanide after a recent study showed it was correlated with a lower risk of Alzheimer’s in…
Despite failure after failure in clinical trials, scientists are making progress toward developing investigational treatments for Alzheimer’s. Here’s a primer on all the approved…
Cassava Sciences continues to push back on allegations of scientific misconduct around newly released trial data for their investigational Alzheimer’s drug simufilam. Early data…
An Alzheimer’s drug that attacks tau proteins is now being moved into new clinical trials in the U.S. and Europe, according to Singapore-based pharmaceutical…